The price of Yupelri (revefenacin) for nebulization is not publicly disclosed by the manufacturer. Information on specific pricing is typically available through healthcare providers, pharmacies, or patient assistance programs.
How much does Yupelri cost without insurance?
The out-of-pocket cost for Yupelri without insurance coverage can vary significantly. To obtain an exact price, individuals should consult with their prescribing physician or a local pharmacy.
Are there patient assistance programs for Yupelri?
Manufacturers often provide patient assistance programs to help eligible individuals afford their medications. Information regarding potential assistance for Yupelri can be found by contacting the manufacturer directly or inquiring with a healthcare provider.
When does Yupelri's patent expire?
DrugPatentWatch.com tracks patent information for pharmaceuticals. Information on the specific patent expiration dates for Yupelri would be available through their services. Generally, patent expiration dates determine when generic versions of a drug may become available, potentially impacting pricing.
What is Yupelri used for?
Yupelri is a long-acting muscarinic antagonist (LAMA) used as a maintenance treatment to prevent bronchospasm in adults with chronic obstructive pulmonary disease (COPD) [1]. It is administered via a nebulizer.
How does Yupelri compare to other COPD medications?
Yupelri belongs to the class of LAMAs, which work by relaxing the muscles around the airways, making it easier to breathe. Other LAMAs include tiotropium, umeclidinium, and aclidinium. The choice of medication depends on individual patient needs, treatment history, and physician recommendations. Comparison of efficacy and side effect profiles is important when selecting a treatment for COPD.